Roche - Ihealthfull

pharma

Giredestrant launch details: Is it the best move for Roche?

Joseph Davis Oct 23, 2026 0

Giredestrant launch details are crucial for Roche's future. Find out what was revealed during the Q3 earnings call.

Read More

YOU MAY HAVE MISSED

pharma

Giredestrant launch details: Is it the best move for Roche?

Joseph Davis Oct 23, 2026

anti-cancer drug prices

pharma

Anti-cancer drug prices: Clear savings with 70% reduction!

Joseph Davis Oct 19, 2026

HL Mando Anand stake acquisition

pharma

HL Mando Anand Stake Acquisition: Clear Insights for Investors

Joseph Davis Oct 15, 2026

FDA approval for WELTRUZA

pharma

FDA Approval for WELTRUZA: A Proven Treatment Option

Joseph Davis Oct 10, 2026